The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of putative resistance mechanisms in recent treatments targeting the androgen receptor in castration-resistant prostate cancer (CRPC).
Paul Thelen
Honoraria - Janssen-Cilag
Other Remuneration - Janssen-Cilag
Eiko Walleck
No relevant relationships to disclose
Felix Bremmer
No relevant relationships to disclose
Lutz Trojan
Honoraria - Janssen-Cilag
Arne Strauß
Honoraria - Janssen-Cilag